Objective: Endovascular aneurysm repair (EVAR) has progressively expanded to treat more challenging anatomies. Although EVAR in patients with wide infrarenal necks has been reported with acceptable results, there is still controversy regarding the longer-term outcomes. Our aim is to determine the impact of infrarenal neck diameter on midterm outcome following EVAR with a single endograft with suprarenal fixation.
Methods: A retrospective case-control study was designed using data from a prospective multicenter database. Patients who electively underwent standard EVAR with an Endurant stent graft (Medtronic Ave, Santa Rosa, Calif) for a degenerative abdominal aortic aneurysm from January 2008 to December 2012 in three high-volume centers in The Netherlands were included. All measurements were obtained using dedicated reconstruction software and centerlumen line reconstruction. Patients with an infrarenal neck diameter of $30 mm were compared with patients with a neck diameter of <30 mm. The primary end point was freedom from neck-related adverse events (a composite of type Ia endoleak, neck-related secondary intervention, and endograft migration). Secondary end points were primary clinical success, type Ia endoleak, neck-related reinterventions, endoleaks, and aneurysm-related secondary interventions.
Results: Four-hundred twenty-seven patients were included. Seventy-four patients (17.3%) with a neck diameter of $30 mm were compared with a control group of 353 patients. There were no significant differences at baseline between groups including demographics, comorbidities, baseline aneurysm diameter, infrarenal neck length, suprarenal angulation, or infrarenal neck angulation. Median stent graft oversizing was 12.5% (7.9-16.1) and 16 .6% (12.0-23.1) in the $30-mm neck-diameter and control groups, respectively (P < .001). Median follow-up was 3.1 years (1.2-4.7) and 4.1 years (2.7-5.6) for the large neck and control groups, respectively (P < .001). Type Ia endoleaks occurred in 17 patients (4.0%) and were significantly more frequent in patients with $30-mm neck diameter (9.5% vs 2.8%; P ¼ .005). Neck-related secondary interventions were performed in 20 patients (4.7%) and were also more common among patients with neck diameters of $30 mm (9.5% vs 3.7%; P ¼ .04). The 4-year freedom from neck-related adverse events were 75% and 95% for the large neck and control groups, respectively (P < .001). On multivariable regression analysis, infrarenal neck diameter of $30 mm was an independent risk factor for neck-related adverse events (odds ratio [OR], 3.8; 95% confidence interval [CI], 1.6-9.1), type Ia endoleak (OR, 2.7; 95% CI, 1.0-8.3), and neck-related secondary interventions (OR, 3.2, 95% CI, 1.1-9.2).
Conclusions: EVAR in patients with large diameter necks is associated with an increased risk of neck-related adverse events in midterm follow-up. This may influence the clinical decision regarding choice of repair and toward a more intensive surveillance following EVAR in these patients in the long term. (J Vasc Surg 2017;65: 1608-16.) Endovascular aneurysm repair (EVAR) is currently the preferred repair method for abdominal aortic aneurysms. 1 Endografts have progressively improved to cope with increasingly more complex anatomies, particularly at the infrarenal neck and together with increased physician proficiency have broadened the range of patients eligible for EVAR.
EVAR in patients with hostile aneurysm necks is associated with an increased risk of adverse events. 2 Although EVAR in patients with wide necks has been reported with acceptable results over short-term follow-up, long-term results conflict. 3, 4 Moreover, most series include different endografts with distinct instructions for use, which greatly reflect the performance of the stent graft in challenging aortic necks. Consequently, the overall understanding of the outcomes of EVAR in these patients is not adequately supported by data. To expand the range of anatomically eligible patients, EVAR device industry has, among other innovations, increased the range of commercially available proximal graft diameters. This has led to generalization of implants in proximal attachment zones in diameter of $30 mm that per definition are already aneurysmal. Therefore, our objective was to determine midterm outcomes following EVAR with a single endograft in patients with large diameter aneurysm necks. Our hypothesis is that EVAR in patients with an infrarenal neck diameter of $30 mm is associated with an increased risk of neckrelated complications.
METHODS
Design and population. A retrospective case-control study was designed based on a prospectively maintained database from three high-volume centers in The Netherlands (Erasmus University Medical Center, Rotterdam; St. Antonius Hospital, Nieuwegein; and University Medical Center, Utrecht). This study complies with the Declaration of Helsinki in research ethics. Informed consent was waived according to institutional policy on retrospective research. Consecutive patients undergoing an elective primary EVAR with an Endurant stent graft (Medtronic, Santa Rosa, Calif) between January 2008 and December 2012 for infrarenal abdominal aortic aneurysms were included. Anastomotic, infectious, or isolated iliac aneurysms were excluded. In addition, patients receiving adjunctive endoanchors during the primary repair, without preoperative computerized tomography (CT) or postoperative CT imaging available for analysis were also excluded.
Patients with a reference infrarenal neck diameter of $30 mm were included in the study group and the remaining population as controls.
Measurements. All measurements were performed by two observers trained in image analysis (N.O., F.B.G.), using dedicated postprocessing software (3Mensio Vascular, Bilthoven, The Netherlands). Preoperative, 30-day and last available CTs were analyzed following center-lumen line reconstruction. In previous reports, high rates of interobserver agreement regarding aneurysm diameter, neck diameter, neck length, and proximal seal length measurements have been demonstrated with this methodology by our group. 5, 6 Aneurysm-volume and neck angulation were also measured according to previously validated methodology. 7, 8 Intraobserver variability for neck diameter and aneurysm-sac volume was tested for 59 patients, with very good agreement (Pearson correlation coefficient: neck diameter, 0.994; P < .001; aneurysm volume, 0.992; P < .001; Fig 1) .
Definitions. Neck diameters were measured in two perpendicular axes just distal to the lowermost renal artery ostium, and at every 5 mm distally along the first 15 mm of the infrarenal neck on center-lumen line reconstructed imaging. The reference neck diameter was considered as the average of the two largest neck measurements. In patients with a neck length of <15 mm, the average of the first two measurements was taken as the reference diameter. This reference neck diameter was used to select the study group (diameter $30 mm) and to calculate oversizing. For assessment of neck dilatation, neck diameter was measured on the 30-day CT angiography (CTA) at the top of the first covered stent of the endograft. The lowermost renal artery was used as landmark; the distance separating the start of the covered stent and the lowermost renal artery at 30-day imaging was used to determine the point of measurement on the preoperative imaging and at last CT, as well as to determine any endograft migration.
Neck configuration was classified according to published methodology. 9 Briefly, neck diameter variations of 10% along the neck length were considered as indicative of nonparallel aortic walls. Aortic necks demonstrating progressive diameter increments $10% along their length were considered as inversed tapered neck (type II) configuration. Neck thrombus and calcification were classified according to circumferential involvement of the neck within the proximal seal zone. Patient comorbidities and aneurysm-related outcomes were reported according to the Society for Vascular Surgery reporting standards. 10 Accordingly, sac growth was defined as >5% increase in aneurysm sac volume or as >5-mm increase in sac diameter following EVAR. Endograft migration was calculated as the difference of the distance between the start of the first covered stent and the lowermost renal artery on the last available and the 30-day CT. Neck-related adverse events were considered to have occurred when a type Ia endoleak or distal endograft migration of >10 mm during followup were identified, or when a secondary intervention related to the infrarenal neck (Palmaz stent, proximal cuff, other endovascular intervention, or open conversion) was performed.
ARTICLE HIGHLIGHTS
Postoperative surveillance. During the study period, typical follow-up protocols included a 30-day and yearly CTA. However, according to the expectation of the treating physician, in selected patients with an anticipated lower risk of complications or renal function impairment, CTA was replaced by an annual colored, duplex ultrasound (DUS) or by noncontrasted CT. Upon the detection of an adverse outcome on these imaging modalities, such as sac enlargement of >5 mm or an endoleak other than a type II endoleak, the patient would undergo a CTA.
End points. The primary study end point was neckrelated adverse events. Secondary end points were type Ia endoleaks, freedom from neck-related reinterventions, clinical success as defined by the Society for Vascular Surgery standards, endoleaks, and aneurysm-related secondary interventions. 10 Association between baseline characteristics and variation of morphologic neckrelated features following EVAR was assessed.
Statistical analysis. Continuous non-normally distributed variables are presented median, interquartile range (IQR), or range and normally distributed variables as mean and standard deviation. Differences between groups were analyzed using Mann-Whitney U test for independent samples. Categorical variables are presented as count and percentage and were compared using the Pearson c 2 test. A multivariable logistic regression model was created for risk assessment of the main outcomes, including variables with a value of #.05 on univariate analysis, if multicollinearity was not identified, as well as age and sex. Time was included as a covariate to adjust for the differences in follow-up time. Confidence intervals (CIs) of 95% were used and statistical significance was considered for a value of <.05. Survival curves were estimated by Kaplan-Meier methods, and equality was assessed with the Mantel-Cox log rank test. All statistical analyses were performed using SPSS v 21.0 (IBM Inc, Chicago, Ill).
RESULTS
During the study period, 472 of the 1054 EVARs were elective primary Endurant stent graft implantations. Twelve anastomotic pseudoaneurysms, 9 isolated iliac aneurysms, 2 aortic dissections, and 1 infectious aneurysm were excluded. Among the remaining population of 448 patients, there were another 21 patients who were excluded: four patients died before performing any postoperative imaging (three of respiratory complications, one from urosepsis), one patient was converted intraoperatively because of inaccurate low deployment in angulated neck anatomy, one patient was lost to follow-up, and 30-day CT imaging was not available for 15 patients.
Overall, 427 patients with a median follow-up of 3.9 years (IQR, 2.3-5.4 years) were included. Seventy-four patients (17.3%) had an infrarenal neck diameter of $30 mm and formed the study group; the remaining were considered as controls (n ¼ 353). Median clinical follow-up was shorter for the $30-mm neck diameter group (3.1 years; IQR, 1.2-4.9 years) compared with the controls (4.1 years; IQR, 2.7-5.6 years; P < .001). CT imaging follow-up was also shorter among the $30-mm neck diameter group (2.0 years; IQR, 0.1-3.7 years) than for the controls (2.9 years; IQR, 1.1-4.6 years; P ¼ .004). Baseline demographic, morphologic, and device-related data is presented in Table I . In the study group, there were more patients with reversed tapered necks (P ¼ .003), and stent grafts were less oversized (P # .001). Endograft oversizing of #10% was found in 26 patients with neck diameters $30 mm (35.6%) and among 56 control patients (16.0%; P # .001).
Neck-related adverse events. During follow-up, 29 patients (6.8%) presented neck-related complications; 12 in the $30-mm neck diameter group (16.2%) and 17 controls (4.9%; P < .001; Table II ). This appeared unrelated to the degree of oversizing. Stent graft oversizing was #10% in seven patients out of these 29 patients (25.0%), whereas this was found in 74 out of the remaining 398 patients (18.6%; P ¼ .43). Median endograft oversizing was 14.6% (IQR, 7.6%-18.5%) for patients presenting neckrelated adverse events and 16.1% (IQR, 12.0%-21.7%) for the remaining patient subset (P ¼ .152). One-year freedom from neck-related adverse events was 95.2% for the $30-mm neck diameter group and 98.8% for the controls, whereas at 4 years, it was 75.2% and 95.2%, respectively (P < .001; Fig 2) . In multivariable regression, neck diameter of $30 mm was associated with a 3.8-fold risk increase of neck-related complications (95% CI, 1.6-9.1). Among the remaining covariates included in the regression model (neck thrombus $25%, inversed tapered neck, oversizing, age, sex, and follow-up time), only neck thrombus was also identified as an independent risk factor for neck complications (odds ratio [OR], 2.8, 95% CI, 1.1-7.3; P ¼ .03).
Secondary end points. The vast majority of neckrelated adverse events were type Ia endoleaks (17 of the 29 patients, 58.6%). The incidence of type Ia endoleaks Neck-related secondary interventions were performed in 21 patients (4.9% overall population). Neck diameter of $30 mm was associated with a 3.2-fold increased risk of neck-related secondary interventions (95% CI, 1.1-9.2). One-year freedom from neck-related interventions was 100% and 99.1% for the $30-mm neck diameter and control groups, whereas at 4 years, it was 92.2% and 98.4%, respectively (P ¼ .001).
Reversed tapered neck configuration was not found to be an independent risk factor for any of the outcomes (neck-related adverse event: OR, 0.85; 95% CI, 0.35-2.06; P ¼ .72; type Ia endoleak: OR, 0.89; 95% CI, 0.29-2.68; P ¼ .83; neck-related secondary intervention: OR, 0.56; 95% CI, 0.18-1.75; P ¼ .32). In a subanalysis excluding all patients with reversed tapered neck configuration, patients with a neck diameter of $30 mm were still at an increased risk of neck-related adverse events (OR, 4.1; 95% CI, 1.44-11.71; P ¼ .008) and neck-related secondary interventions (OR, 3.48; 95% CI, 1.06-11.4; P ¼ .04).
Thrombotic coverage of the infrarenal neck $25% of its circumference was not found as a risk factor for none of the individual end points which form the primary end point (type Ia endoleak, neck-related secondary interventions).
Freedom from secondary interventions was 72.4% and 84.5% at 4 years for the wide neck and control groups (P ¼ .09). Primary clinical success at 1 year was 72.5% for the $30-mm neck diameter group and 90.4% for the control group, whereas at 4 years, it was 36.3% and 56.1%, respectively (P < .001; Fig 3) .
Patients with $30-mm neck diameter did not present more aneurysm-related adverse events (18.9%) compared with the <30-mm neck group (15.1%; P ¼ .42). Also, secondary interventions were not more frequent among the large neck group (17.6% in the $30-mm group, 19.5% in the <30-mm group; P ¼ .7). In multivariable analysis, patients with infrarenal neck diameter of $30 mm were not at increased risk of presenting none of these outcomes (Table II) .
Neck evolution. Comparing last-available imaging to baseline, the infrarenal neck had dilated a median 4.3 mm (15.7%; IQR, 3.9%-22.6%) in the $30-mm neck diameter group and 3.0 mm, (13.0%; IQR, 4.8%-20.0%) in the controls (P ¼ .45). The median yearly rate of dilatation was 5.7% (IQR, 2.5%-10.4%) and 4.0% (IQR, 2.2%-7.6%) for the $30-mm neck diameter and control groups, respectively (P ¼ .07).
DISCUSSION
Over time, endograft-related improvements have resulted in better outcomes following EVAR. 11, 12 Consequently, standard EVAR has been performed in progressively more challenging aortic-neck anatomies extending the benefits of a lower perioperative morbidity and mortality to a broadened group of patients, a finding that is also reflected in population. 13 Considerable controversy still surrounds treatment selection for these patients. Although the reported shortto midterm outcomes following EVAR in these anatomies so far are quite good, others have reported that using an already ectatic and, therefore, diseased neck as proximal sealing zone can lead to less favorable results over time. 2 Our study suggests that EVAR in patients with $30-mm infrarenal neck diameter is associated with an increased risk of neck-related complications at midterm.
In a report from Aburahma et al, 14 no relation was found between neck diameter and type Ia endoleaks or the need of secondary aortic cuffs. However, mean neck diameter was only 25.3 mm (range, 16-32 mm), and only 19 patients (8%) had a neck diameter of >28 mm. Similar results were also reported from the Endurant Stent Graft Natural Selection Global Postmarket Registry (ENGAGE) registry by Bastos Gonçalves et al. 4 In this large real-world study, the 398 patients (31.5%) treated with 32-or 36-mm diameter Endurant stent grafts were not found to be at increased risk of neck-related adverse events (P ¼ .40). Although those patients were also treated with the same endograft as in our population, only 438 patients in that cohort (38%) had reached the 2-year follow-up threshold, which limited the conclusions. In addition, as the range of aortic neck diameters of these patients receiving a 32-or 36-mm device is not cited nor is the oversizing quantified, this may be a heterogeneous group of patients including patients with smaller neck diameters, which may ultimately disguise the outcomes of those with wide infrarenal necks. In contrast, our report clearly defines a homogenous study group with wide infrarenal neck diameters. In contrast, other reports have associated large infrarenal neck diameter to adverse outcomes following EVAR. In a large multicenter report (N ¼ 10,228), Schanzer et al 15 reported that at a mean follow-up of 31 months (618), patients with large neck diameters were at increased risk of secondary aneurysm sac enlargement. Patients with infrarenal neck diameters of 28-32 mm had a hazard ratio (HR) of 1.8 (95% CI, 1.4-2.2), whereas those patients with neck diameters of >32 mm were at an even higher risk (HR, 2.1; 95% CI, 1.5-2.9). This study was also limited by lack of clinical or device data and by the nonconsecutive nature of their sample. In a more recent study from Stather et al 16 including 552 patients followed for Our study included only patients treated with Endurant stent grafts, which are approved for patients with aortic neck diameters up to 32 mm. The increased conformability and active suprarenal fixation of this device result in the reported good performance of this device in many challenging infrarenal neck anatomies, conferring it highly resistant to distal migration, which is also supported by our current report. However, although no distal migrations were identified in the $30-mm neck diameter group, these patients developed more neck-related complications including type Ia endoleaks. Our findings suggest that the mode of failure is distinct between different endografts. In contrast to other devices, loss of proximal seal with the Endurant stent graft is mainly due to progressive aortic neck dilatation, and not distal migration. 18 Importantly, serial simple abdominal X ray and DUS have a limited value detecting progressive seal loss as it will occur without distal migration and will be undetectable until the occurrence of a type Ia endoleak, which then puts the patient at risk of aneurysm rupture. We think that currently available adjuncts to increase proximal fixation such as endoanchors may be of limited benefit as secondary intervention in wideneck patients treated with this stent graft who experience progressive loss of proximal. Whether endoanchors prevent further neck dilatation when used during the primary EVAR in wide necks is an interesting concept, which has not been studied so far. Neck dilatation following EVAR is a well-known event, particularly with oversized self-expanding endografts, because of the chronic outward radial force on the infrarenal neck. 21 In addition, the infrarenal neck has been demonstrated to be histologically diseased, which may lead to progressive dilatation. 22 In our study, although patients with neck diameters of $30 mm did not present more neck dilatation compared with the control group, these results should be interpreted cautiously as an increased yearly dilatation rate was observed despite a shorter follow-up time and reduced endograft oversizing in this patient group. Importantly, we reported a median neck dilatation of 4.1 mm and 3.0 mm in the $30-mm and <30-mm neck groups. However, neck diameter measurements were performed only at a single point and not throughout the whole length of the neck, which explains why type Ia endoleaks were not identified in all patients presenting neck dilatation. Our findings are in line with those reported by Cao et al 23 who found preoperative neck diameter to be predictive of dilatation (HR, 1.21; 95% CI, 1.07-1.35). We hypothesize that the infrarenal neck in these patients may be more diseased leading to an increased rate of dilatation given an equal follow-up time, although confirmatory histologic studies are not available. In addition, we consider that although increased oversizing, if technically feasible, might be able to accommodate a greater increase in the aortic neck diameter, the expectable reduction of the number of neck-related seal complications would be limited in time and ultimately develop over the longer term. Neck thrombus was more common in the wide-neck group. Although considered a hostile neck feature, our group has previously challenged this concept. 10, 24 However, in our study, it was identified as an independent predictor of neck adverse events but not for type Ia endoleaks or neck-related secondary interventions individually. We consider that the combination of neck thrombus with wide neck diameter may render patients at an increased risk of neck-related complications.
There are noteworthy limitations of our study. First, about 41% of the patients included in the $30-mm neck diameter group did present an inversed tapered neck configuration, which is distinct from the truly wide aneurysm neck group and consequently may hinder our results. However, a subanalysis excluding these patients was provided and still the influence of a wide neck diameter on outcomes is notorious. Moreover, our purpose was to capture a real-world clinical setting, where these patients are commonly treated by standard EVAR. This fact accounts also for the significantly shorter CT-imaging follow-up compared with clinical follow-up, as surveillance imaging has resorted mostly to annual DUS. Yet, in The Netherlands, patients are followed in the original EVAR-providing hospital in case of complications, and so and the chance of missing important data on complications or secondary interventions is reduced. Secondly, its retrospective nature introduces a potential selection bias, thus, contributing to the significantly different follow-up time among groups. Nevertheless, all patients were consecutively treated, and our results express contemporary real-world EVAR practices where patients with challenging neck features have more recently been treated with standard EVAR as experience has grown. Also, the single-endograft inclusion criterion limits extrapolation of our findings to other EVAR populations but allowed group comparison without interaction with other stent graft designspecific factors and may be clinically relevant to other centers performing EVAR with this stent graft. Although we could only present midterm follow-up data, patients were followed prospectively and life-table analysis was performed demonstrating significant differences at this time.
In conclusion, we found that standard EVAR in patients with $30 mm proximal neck diameter is associated with an increased risk of neck-related adverse events (type Ia endoleaks, neck-related secondary interventions). Consequently, two recommendations can be made. First, we suggest that in patients with infrarenal aortic neck diameters of $30 mm, the risks, costs, and expected outcomes of other treatment modalities (fenestrated EVAR, chimney, and open aortic repair) should be carefully weighed against the higher risk of neck-related adverse events in these patients. Second, in patients with $30-mm infrarenal neck diameter treated with standard EVAR, CT imaging should not be waived completely as postoperative imaging protocols based on DUS/simple X ray alone will not allow the detection of neck dilatation and/or loss of proximal seal before the development of a type Ia endoleak, thus, leaving the patient at risk of rupture.
